Entera Bio (ENTX) Assets (2017 - 2026)
Entera Bio's (ENTX) quarterly Assets came in at $13.1 million in Q1 2026, down 39.22% YoY from $21.6 million in Q1 2025, and down 17.91% on a QoQ basis from $16.0 million in Q4 2025.
Entera Bio (ENTX) Assets (2017 - 2026) Analysis & Trends
Entera Bio (ENTX) has 10 years of Assets data on file, last reported at $13.1 million in Q1 2026.
- Quarterly Assets fell 39.22% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.1 million (down 39.22% YoY) and the FY2025 annual result came in at $16.0 million, up 70.32% from the prior year.
- Assets eased to $13.1 million in Q1 2026, from $16.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $22.3 million in Q1 2022 to a low of $7.7 million in Q3 2024.
- A 5-year average of $14.0 million and a median of $13.1 million in 2022 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets tumbled 49.49% — and 2025, when it soared 124.87%.
- Tracing ENTX's Assets over 5 years: stood at $13.1 million in 2022, then dropped by 10.38% to $11.8 million in 2023, then decreased by 20.19% to $9.4 million in 2024, then jumped by 70.32% to $16.0 million in 2025, then slipped by 17.91% to $13.1 million in 2026.
- The last three Assets figures came in at $13.1 million (Q1 2026), $16.0 million (Q4 2025), and $17.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Entera Bio | 164.09 Mn | 152.78 Mn | - | 19.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.48 Mn |
| Mar 31, 2026 | 13.13 Mn |
| Dec 31, 2025 | 15.99 Mn |
| Sep 30, 2025 | 17.41 Mn |
| Jun 30, 2025 | 19.67 Mn |
| Mar 31, 2025 | 21.60 Mn |
| Dec 31, 2024 | 9.39 Mn |
| Sep 30, 2024 | 7.74 Mn |
| Jun 30, 2024 | 10.04 Mn |
| Mar 31, 2024 | 10.24 Mn |
| Dec 31, 2023 | 11.77 Mn |
| Sep 30, 2023 | 8.57 Mn |
| Jun 30, 2023 | 10.45 Mn |
| Mar 31, 2023 | 11.61 Mn |
| Dec 31, 2022 | 13.13 Mn |
| Sep 30, 2022 | 15.54 Mn |
| Jun 30, 2022 | 19.09 Mn |
| Mar 31, 2022 | 22.31 Mn |
| Dec 31, 2021 | 25.99 Mn |
| Jun 30, 2021 | 28.94 Mn |